Logo-jnp
J Nephropathol. 2019;8(2): e12. doi: 10.15171/jnp.2019.12

Original Article

Mycophenolate mofetil versus cyclophosphamide for idiopathic membranous nephropathy; a double blind and randomized clinical trial

Fatemeh Hayati 1, Heshmatollah Shahbazian 1, Ali Ghorbani 1, Shahla Ahmadi Halili 1 * , Eisa Rezaei 1, Leila Sabetnia 1, Seyed Seifollah Beladi Mousavi 1,2

Cited by CrossRef: 1

1- Bao N, Gu M, Yu X, Wang J, Gao L, Miao Z, Kong W. Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis. 2023;18(1) [Crossref]
2- Feng C, Chen X, Wang X, Guo M, Guo Z. Efficacy and safety of glucocorticoid combined with cyclophosphamide therapy on membranous nephropathy: a systematic review and meta-analysis. Front Pharmacol. 2024;15 [Crossref]